7 results
SC 14D9
STSA
Satsuma Pharmaceuticals Inc
5 May 23
Tender offer solicitation
8:17am
to conclude the Transaction or an alternative strategic transaction would force it to consider other strategic alternatives such as wind-down … to the total assets of the Company minus the total liabilities of the Company, each as of the date of the analysis, minus wind down charges incurred
8-K
EX-2.1
STSA
Satsuma Pharmaceuticals Inc
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
and wind-down.”
SCHEDULE III
Company Net Cash Calculation
Exhibit A
Form of Tender and Support Agreement
Exhibit B
Certificate of Merger
CERTIFICATE
S-1
EX-4.5
STSA
Satsuma Pharmaceuticals Inc
16 Aug 19
IPO registration
5:15pm
, dissolve or wind up; or
(e) effect its initial, underwritten offering and sale of its securities to the public pursuant to an effective registration
S-1
EX-10.7
STSA
Satsuma Pharmaceuticals Inc
16 Aug 19
IPO registration
5:15pm
will have a reasonable time period following the Start Date during which to wind down such obligations and activities, provided that such activities do
S-1
EX-4.4
868qgft2 5m
16 Aug 19
IPO registration
5:15pm
DRS/A
EX-10.7
vpstpsny914dkjypzv
2 Aug 19
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next